G Medical Innovations Holdings Ltd
Change company Symbol lookup
Select an option...
GMVD G Medical Innovations Holdings Ltd
CMPX Compass Therapeutics Inc.
AMST Amesite Inc
AMPX Amprius Technologies Inc
PRTK Paratek Pharmaceuticals Inc
EGRAY Energy Resources Of Australia Ltd
IVAC Intevac Inc
PFE Pfizer Inc
BNOX Bionomics Ltd
CRKN Crown Electrokinetics Corp.
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Providers & Services | Small Cap Value
Based in Cayman Islands
Company profile

G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.

Closing Price
$0.91
Day's Change
-0.75 (-45.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.13
Day's Low
0.89
Volume
(Heavy Day)
Volume:
14,375,129

10-day average volume:
1,803,160
14,375,129

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 3, 2023 in Enviva Lawsuit - EVA

7:09 am ET January 3, 2023 (Newsfile) Print

New York, New York--(Newsfile Corp. - January 3, 2023) - Levi & Korsinsky, LLP notifies investors in Enviva Inc. (NYSE: EVA) ("Enviva" or the "Company") of a class action securities lawsuit.

The lawsuit on behalf of Enviva investors has been commenced in the the United States District Court for the District of Maryland. Affected investors purchased or otherwise acquired certain Enviva Inc. securities between February 21, 2019 and October 11, 2022. Follow the link below to get more information and be contacted by a member of our team:

https://www.zlk.com/pslra-1/enviva-class-action-submission-form?prid=35239&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7091/150142_161609_logo.jpg





Cannot view this video? Visit:

https://www.youtube.com/watch?v=HoeGbaLi450

Enviva Inc. NEWS - EVA NEWS

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Enviva had misrepresented the environmental sustainability of its wood pellet production and procurement; (ii) Enviva had similarly overstated the true measure of cash flow generated by the Company's platform; (iii) accordingly, Enviva had misrepresented its business model and the Company's ability to achieve the level of growth that defendants had represented to investors; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT THIS MEANS TO SHAREHOLDERS: If you suffered a loss in Enviva during the relevant timeframe, you have until January 3, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. Discuss your rights with our legal team without cost or obligation.

PROTECT YOUR FINANCIAL INTERESTS: Complete this brief submission form https://www.zlk.com/pslra-1/enviva-class-action-submission-form?prid=35239&wire=5 or call 212-363-7500 to discuss the case.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/150142

comtex tracking

COMTEX_421817976/2523/2023-01-03T07:09:10

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.